SARS-CoV-2 Nucleocapsid Protein Antibody | abx376481

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein (NP) Antibody is a chimaeric recombinant Monoclonal Antibody expressed in CHO cells against SARS-CoV-2/COVID-19 NP, containing Mouse variable region and Human IgG1 constant region.

The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.

Target: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein
Clonality: Monoclonal
Reactivity: Virus
Origin: Human
Expression: Recombinant
Tested Applications: ELISA, WB
Host: Human, Mouse
Recommended dilutions: ELISA: 1/5000 - 1/10,000, WB: 1/1000 - 1/2000. Optimal dilutions/concentrations should be determined by the end user.
Conjugation: Unconjugated
Immunogen: Recombinant SARS-CoV-2 Nucleocapsid Protein
Isotype: IgG1
Form: Liquid
Purification: Purified by affinity chromatography.
Storage: Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.